Clinical Efficacy And Safety of Montmorillonite Powder in the Treatment of Irritable Bowel Syndrome(IBS)
Objective:To study the efficacy and safety of montmorillonite powder in the treatment of irritable bowel syndrome(IBS).Methods:Sixty patients with IBS treated in the hospital from May 2017 to May 2022 were selected and divided into control group and study group according to different treatment schemes,with 30 patients in each group.The control group was treated with Livzon Changle,while the study group was treated with montmorillonite powder.The efficacy and safety of the two groups were compared.Results:The total effective rate of the study group was higher than that of the control group,P<0.05.The incidence of adverse reactions in the study group was lower than that in the control group,P<0.05;Before treatment,the gastrointestinal hormone indexes of the two groups were compared,P>0.05;After treatment,the indexes of gastrointestinal hormones in the study group were lower than those in the control group,P<0.05.Before treatment,the symptoms of the two groups were graded and com-pared,P>0.05;After treatment,the symptom grade of the study group was lower than that of the control group,P<0.05.Conclusion:Montmorillonite powder can improve the efficacy and safety of medication for IBS patients,and grad-ually improve gastrointestinal symptoms and gastrointestinal function.
国家科技期刊平台
NSTL
万方数据
